<SEC-DOCUMENT>0001104659-26-030243-index.html : 20260318
<SEC-HEADER>0001104659-26-030243.hdr.sgml : 20260318
<ACCEPTANCE-DATETIME>20260318110706
ACCESSION NUMBER:		0001104659-26-030243
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260318
FILED AS OF DATE:		20260318
DATE AS OF CHANGE:		20260318

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dyer Timothy Mark
		CENTRAL INDEX KEY:			0001830908
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39179
		FILM NUMBER:		26766813

	MAIL ADDRESS:	
		STREET 1:		CHEMIN DES MINES 9
		STREET 2:		CH-1202
		CITY:			GENEVA
		STATE:			V8
		ZIP:			CH-1202

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Addex Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001574232
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		CHEMIN DES MINES 9
		CITY:			GENEVA
		STATE:			V8
		ZIP:			CH-1202
		BUSINESS PHONE:		01141228841555

	MAIL ADDRESS:	
		STREET 1:		CHEMIN DES MINES 9
		CITY:			GENEVA
		STATE:			V8
		ZIP:			CH-1202
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm268906-3_3seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm268906-3_3seq1.html

Document 1 - RAW XML: tm268906-3_3seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>